Tag: CAR-T Cell Therapy

A bacterial metabolite that circulates in the blood of patients colonized with carbapenem-resistant Klebsiella pneumoniae appears to sabotage one of ...

Chimeric antigen receptor T-cell therapy has transformed the treatment of several blood cancers, yet its success often depends on how ...

CAR T-cell therapy has changed the outlook for people with some of the most aggressive blood cancers, turning a patient’s ...

For years, CAR-T cell therapy has stood as one of cancer medicine’s most striking successes. By removing a patient’s T ...

A new review published in Oncoscience argues that the next generation of CAR-T therapy for solid tumors will depend less ...

Yousefian, S., Schubert, ML., Minafra, A.R. et al. A distinct CAR-T cell phenotype mediates therapeutic response at limited doses. Nat ...

In the evolving landscape of multiple myeloma treatment, researchers are pursuing novel therapies to enhance patient outcomes, particularly for those ...

In a groundbreaking study published in Nature Chemical Biology, researchers elucidate the transformative potential of intracellular delivery of multivalent binding ...

Cancer immunotherapy has revolutionized the landscape of blood cancer treatment, especially through the deployment of bioengineered T cells. Among these, ...

In the rapidly evolving landscape of cancer treatment, the emergence of immune-based cell therapies heralds a new era of hope ...